Testing effectiveness (Phase 2)Study completedNCT00087867What this trial is testingStudy of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Scios, Inc. 62
Not applicableStudy completedNCT04121767What this trial is testingSafety and Efficacy of Edoxaban in Thoracoscopic AblationWho this might be right forAtrial FibrillationAnticoagulants and Bleeding Disorders Samsung Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT02874326What this trial is testingOctreotide in Patients With GI Bleeding Due to Rendu-Osler-WeberWho this might be right forHereditary Hemorrhagic TelangiectasiaGastrointestinal HemorrhageAnemia Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT04684940What this trial is testingSafety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia A With Anti Factor VIII BioMarin Pharmaceutical 10
Post-approval studies (Phase 4)Study completedNCT06425276What this trial is testingEvaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC TransplantationWho this might be right forMultiple Myeloma CASI Pharmaceuticals (China) Co., Ltd. 67
Large-scale testing (Phase 3)Study completedNCT01286779What this trial is testingBAX 326 (rFIX) Continuation StudyWho this might be right forHemophilia B Baxalta now part of Shire 117
Early research (Phase 1)Study completedNCT01353625What this trial is testingStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.Who this might be right forGlioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more Celgene 118
Not applicableStudy completedNCT04151615What this trial is testingVMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Boryung Pharmaceutical Co., Ltd 203
Large-scale testing (Phase 3)Study completedNCT03370913What this trial is testingSingle-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)Who this might be right forHemophilia A BioMarin Pharmaceutical 144
Testing effectiveness (Phase 2)Looking for participantsNCT06232096What this trial is testingMBS314 in Participants With Relapsed/Refractory Multiple Myeloma.Who this might be right forRelapsed or Refractory Multiple Myeloma Beijing Mabworks Biotech Co., Ltd. 154
Large-scale testing (Phase 3)Active Not RecruitingNCT06045806What this trial is testingCompare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell TransplantationWho this might be right forMultiple Myeloma Celgene 79
Large-scale testing (Phase 3)Study completedNCT00708435What this trial is testingEfficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant TherapyWho this might be right forBlood Coagulation DisordersAcute Major Bleeding CSL Behring 216
Early research (Phase 1)Study completedNCT00555100What this trial is testingSafety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 15
Post-approval studies (Phase 4)Looking for participantsNCT06608992What this trial is testingEvaluation of the Effect of SURGICEL® Powder in TKAWho this might be right forKnee Osteoarthritis Peking University Third Hospital 112
Testing effectiveness (Phase 2)Study completedNCT00402181What this trial is testingAn Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Centocor, Inc. 53
Early research (Phase 1)Looking for participantsNCT07073547What this trial is testingA Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)Who this might be right forMultiple Myeloma AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT05749133What this trial is testingSafety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MMWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory XuYan 18
Very early researchLooking for participantsNCT06407947What this trial is testingStudy of CT071 Injection in High Risk Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Shanghai Changzheng Hospital 10
Early research (Phase 1)Study completedNCT04322292What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forMultiple Myeloma Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Study completedNCT00378209What this trial is testingBortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Dana-Farber Cancer Institute 65